108 related articles for article (PubMed ID: 8763680)
1. [Prevention of venous thromboembolic disease].
Samama MM
Rev Prat; 1996 May; 46(10):1245-53. PubMed ID: 8763680
[TBL] [Abstract][Full Text] [Related]
2. Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patients.
Haas S
Semin Thromb Hemost; 1999; 25 Suppl 3():101-5. PubMed ID: 10549724
[TBL] [Abstract][Full Text] [Related]
3. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
Bergqvist D
Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
[TBL] [Abstract][Full Text] [Related]
4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
5. [Assessing the use of low-molecular-weight heparins fo venous thromboembolism prophylaxis in internal medicine patients].
Villar Fernández I; Urbieta Sanz E; Arenere Mendoza M; López Larramona G; Marcilla Córdoba F; Rabanaque Hernández MJ
Farm Hosp; 2004; 28(6):402-9. PubMed ID: 15628942
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolic risk and its prevention in hospitalized medical patients.
Haas SK
Semin Thromb Hemost; 2002 Dec; 28(6):577-84. PubMed ID: 12536351
[TBL] [Abstract][Full Text] [Related]
7. [Thrombosis prophylaxis with heparins in intensive care patients].
Greinacher A; Janssen D
Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Mar; 40(3):156-63. PubMed ID: 15770559
[TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
Burris HA
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
[TBL] [Abstract][Full Text] [Related]
9. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
10. Perioperative thrombosis prophylaxis with low molecular weight heparins in elective hip surgery. Clinical and economic considerations.
Borris LC; Lassen MR; Jensen HP; Andersen BS; Poulsen KA
Int J Clin Pharmacol Ther; 1994 May; 32(5):262-8. PubMed ID: 7921522
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of venous thrombosis in cancer patients: practical aspects].
Laza-Achille M; Desruennes E; Di Palma M
Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314
[TBL] [Abstract][Full Text] [Related]
12. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
Cunningham RS
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
[TBL] [Abstract][Full Text] [Related]
13. [Low molecular weight heparin in patients undergoing vascular surgery].
Godet G; Kretz JG; Cristea T
Ann Fr Anesth Reanim; 2005 Apr; 24(4):347-54. PubMed ID: 15826784
[TBL] [Abstract][Full Text] [Related]
14. Prevention of venous thromboembolism.
Pini M; Spyropoulos AC
Semin Thromb Hemost; 2006 Nov; 32(8):755-66. PubMed ID: 17171588
[TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
16. Long-term cost-effectiveness of low molecular weight heparin versus unfractionated heparin for the prophylaxis of venous thromboembolism in elective hip replacement.
Marchetti M; Liberato NL; Ruperto N; Barosi G
Haematologica; 1999 Aug; 84(8):730-7. PubMed ID: 10458700
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of complications of major orthopedic surgery: comparison of indobufen, calcium heparin, and low molecular heparin].
Borghi B; Bassi A; Grazia M; Feoli MA; Pignotti E
Minerva Anestesiol; 1996 Mar; 62(3):93-100. PubMed ID: 8767154
[TBL] [Abstract][Full Text] [Related]
18. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials.
Mismetti P; Laporte-Simitsidis S; Tardy B; Cucherat M; Buchmüller A; Juillard-Delsart D; Decousus H
Thromb Haemost; 2000 Jan; 83(1):14-9. PubMed ID: 10669147
[TBL] [Abstract][Full Text] [Related]
19. [Prevention of thrombo-embolic venous disease].
Samama MM; Gerotziafas GT; Horellou MH
Rev Prat; 2003 Jan; 53(1):51-7. PubMed ID: 12673925
[TBL] [Abstract][Full Text] [Related]
20. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
Bell GK; Goldhaber SZ
Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
